Tumour cell conditioned medium reveals greater M2 skewing of macrophages in the absence of properdin

被引:11
|
作者
Al-Rayahi, Izzat A. M. [1 ,2 ]
Browning, Michael J. [1 ,3 ]
Stover, Cordula [1 ]
机构
[1] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England
[2] Coll Hlth & Med Technol, Dept Med Lab Technol, Baghdad, Iraq
[3] Leicester Royal Infirm, Dept Immunol, Leicester, Leics, England
关键词
Macrophages; tumour conditioned medium; complement properdin; COMPLEMENT; POLARIZATION; ACTIVATION; CANCER; PROGRESSION; IL-12; M1;
D O I
10.1002/iid3.142
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: The tumour microenvironment is shaped by the interaction of immune, non immune, and tumour cells present in close proximity. Tumour cells direct the development of a locally immune suppressed state, affecting the activity of anti tumour T cells and preparing the escape phase of tumour development. Macrophages in the tumour typically develop into so-called tumour associated macrophages with a distinct profile of activities which lead to a reduction in inflammation and antigen presentation. The direct impact of tumour cell conditioned medium on the activity profile of macrophages in dependence of their complement component expression has not yet been investigated. Methods: In our in vitro study, macrophages differentiated from bone marrows of properdin deficient and wildtype mice were stimulated with conditioned medium of a syngeneic tumour cell line, B16F10, a mouse melanoma subline. Results: In comparison with macrophages from wildtype mice, those from congenic properdin deficient mice showed skewing towards M2 profile, encompassing mRNA expression for genes involved in arginine metabolism, production of type 2 cytokines, and relatively lower surface expression of molecules needed for antigen presentation. Conclusions: These data suggest that properdin insufficiency promotes a tumour environment that helps the tumour evade the immune response.
引用
收藏
页码:68 / 77
页数:10
相关论文
共 50 条
  • [1] Tumour-conditioned medium skews macrophages to a M2 phenotype, increasing tumour cell invasiveness
    Byrnes, K. G.
    Foley, N. M.
    Hechtl, D.
    Redmond, H. P.
    Wang, J. H.
    BRITISH JOURNAL OF SURGERY, 2015, 102 : 40 - 40
  • [2] NecroX-5 ameliorates inflammation by skewing macrophages to the M2 phenotype
    Nam, Sun-Young
    Shin, Byung-Ho
    Lee, Miji
    Lee, Seunghee
    Heo, Chan Yeong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 66 : 139 - 145
  • [3] M2 macrophages on tumour growth and metastasis in hepatocellular carcinoma
    Man, K.
    Lo, C. M.
    Liu, X. B.
    HONG KONG MEDICAL JOURNAL, 2019, 25 (06) : 35 - 39
  • [4] Substance P as a novel cytokine for induction of alternatively activated M2 polarization and skewing M2 from M1 type of macrophages
    Lim, Ji Eun
    Chung, EunKyung
    Son, Youngsook
    CYTOKINE, 2015, 76 (01) : 68 - 68
  • [5] Metformin Regulates Gut Microbiota Abundance to Suppress M2 Skewing of Macrophages and Colorectal Tumorigenesis in Mice
    Linfeng Fan
    Xiangfu Zeng
    Guofeng Xu
    Journal of Microbiology, 2023, 61 : 109 - 120
  • [6] Ginsenoside Rb1 enhances atherosclerotic plaque stability by skewing macrophages to the M2 phenotype
    Zhang, Xue
    Liu, Ming-hao
    Qiao, Lei
    Zhang, Xin-yu
    Liu, Xiao-ling
    Dong, Mei
    Dai, Hong-yan
    Ni, Mei
    Luan, Xiao-rong
    Guan, Jun
    Lu, Hui-xia
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (01) : 409 - 416
  • [7] Metformin Regulates Gut Microbiota Abundance to Suppress M2 Skewing of Macrophages and Colorectal Tumorigenesis in Mice
    Fan, Linfeng
    Zeng, Xiangfu
    Xu, Guofeng
    JOURNAL OF MICROBIOLOGY, 2023, 61 (01) : 109 - 120
  • [8] Prognostic role of M2 tumour-associated macrophages in lymphoproliferative disorders
    Cencini, Emanuele
    Fabbri, Alberto
    Bocchia, Monica
    JOURNAL OF PATHOLOGY, 2017, 242 (04): : 511 - 512
  • [9] Mesenchymal stem cell-conditioned medium induces microglia into M2 phenotype and promotes amyloid β-phagocytosis
    Iwahara, N.
    Yokokaw, K.
    Saito, T.
    Fujikura, M.
    Manabe, T.
    Matsushita, T.
    Matsumura, A.
    Suzuki, S.
    Hisahara, S.
    Kawamata, J.
    Shimohama, S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 665 - 665
  • [10] Artemisinin ameliorates intestinal inflammation by skewing macrophages to the M2 phenotype and inhibiting epithelial-mesenchymal transition
    Huai, Manxiu
    Zeng, Junxiang
    Ge, Wensong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 91